Expanded PBS listing for SGLT2i for type 2 diabetes

3 minute read


Dapagliflozin is now more broadly subsidised following a price change. Also, two insulin delivery devices have important defects.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×